STAR LAKE BIOSCIENCE CO., INC.ZHAOQING GUANGDONG Financials Star Lake Bioscience Co., Inc.Zhaoqing Guangdong
Equities
600866
CNE000000H46
Food Processing
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.04 CNY | -0.98% |
|
+20.86% | +8.15% |
| Apr. 23 | China stocks down, dragged by cyclical shares; HK shares up | RE |
| Apr. 22 | Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,027 | 3,281 | 3,688 | 4,611 | 9,853 | 7,742 |
| Enterprise Value (EV) 1 | 2,204 | 3,372 | 3,833 | 4,751 | 13,300 | 10,632 |
| P/E ratio | 47.9 x | 21.9 x | 24.8 x | 43.3 x | 11.6 x | 11.4 x |
| Yield | - | - | - | - | - | 8.15% |
| Capitalization / Revenue | 2.36 x | 3.13 x | 3.3 x | 3.73 x | 0.56 x | 0.45 x |
| EV / Revenue | 2.56 x | 3.21 x | 3.43 x | 3.85 x | 0.76 x | 0.61 x |
| EV / EBITDA | 17.3 x | 13.5 x | 15.9 x | 21.5 x | 4.86 x | 5.24 x |
| EV / FCF | 146 x | -33.3 x | 48.4 x | -28.9 x | 13.5 x | 29.3 x |
| FCF Yield | 0.69% | -3% | 2.07% | -3.46% | 7.39% | 3.41% |
| Price to Book | 2.12 x | 2.16 x | 2.21 x | 2.6 x | 1.43 x | 1.02 x |
| Nbr of stocks (in thousands) | 645,393 | 739,019 | 739,019 | 739,019 | 1,661,473 | 1,661,473 |
| Reference price 2 | 3.140 | 4.440 | 4.990 | 6.240 | 5.930 | 4.660 |
| Announcement Date | 3/25/19 | 3/16/20 | 4/26/21 | 3/28/22 | 3/27/23 | 4/22/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 859.1 | 1,050 | 1,116 | 1,235 | 17,486 | 17,374 |
| EBITDA 1 | 127.2 | 249.8 | 241.4 | 220.6 | 2,737 | 2,030 |
| EBIT 1 | 49.47 | 164.4 | 155.3 | 113.9 | 1,762 | 1,185 |
| Operating Margin | 5.76% | 15.66% | 13.92% | 9.22% | 10.08% | 6.82% |
| Earnings before Tax (EBT) 1 | 42.28 | 157.4 | 156.6 | 110.5 | 1,424 | 863.6 |
| Net income 1 | 42.28 | 149.6 | 148.7 | 106.5 | 608.3 | 678 |
| Net margin | 4.92% | 14.25% | 13.32% | 8.62% | 3.48% | 3.9% |
| EPS 2 | 0.0655 | 0.2024 | 0.2012 | 0.1441 | 0.5122 | 0.4080 |
| Free Cash Flow 1 | 15.12 | -101.1 | 79.25 | -164.6 | 982.2 | 363 |
| FCF margin | 1.76% | -9.64% | 7.1% | -13.32% | 5.62% | 2.09% |
| FCF Conversion (EBITDA) | 11.89% | - | 32.83% | - | 35.89% | 17.89% |
| FCF Conversion (Net income) | 35.76% | - | 53.29% | - | 161.46% | 53.55% |
| Dividend per Share | - | - | - | - | - | 0.3800 |
| Announcement Date | 3/25/19 | 3/16/20 | 4/26/21 | 3/28/22 | 3/27/23 | 4/22/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 177 | 90.3 | 145 | 140 | 3,447 | 2,889 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 1.392 x | 0.3614 x | 0.6011 x | 0.6343 x | 1.259 x | 1.423 x |
| Free Cash Flow 1 | 15.1 | -101 | 79.3 | -165 | 982 | 363 |
| ROE (net income / shareholders' equity) | 4.52% | 12.1% | 9.33% | 6.18% | 17.1% | 9.4% |
| ROA (Net income/ Total Assets) | 2.14% | 5.77% | 4.28% | 2.91% | 6.91% | 4.87% |
| Assets 1 | 1,979 | 2,592 | 3,475 | 3,662 | 8,798 | 13,910 |
| Book Value Per Share 2 | 1.480 | 2.060 | 2.260 | 2.400 | 4.140 | 4.550 |
| Cash Flow per Share 2 | 0.1500 | 0.3600 | 0.3100 | 0.3100 | 0.6400 | 0.8500 |
| Capex 1 | 33.7 | 157 | 290 | 205 | 452 | 376 |
| Capex / Sales | 3.92% | 15% | 25.97% | 16.61% | 2.59% | 2.16% |
| Announcement Date | 3/25/19 | 3/16/20 | 4/26/21 | 3/28/22 | 3/27/23 | 4/22/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +8.15% | 1.16B | |
| +2.35% | 29.77B | |
| +4.50% | 21.6B | |
| +13.39% | 11.83B | |
| +12.40% | 5.15B | |
| +11.10% | 4.21B | |
| -16.49% | 3.48B | |
| -3.79% | 3.14B | |
| +4.73% | 3.11B | |
| +27.19% | 2.79B |
- Stock Market
- Equities
- 600866 Stock
- Financials Star Lake Bioscience Co., Inc.Zhaoqing Guangdong
